載入...
Translational studies of intravenous and intracerebroventricular routes of administration for CNS cellular biodistribution for BMN 250, an enzyme replacement therapy for the treatment of Sanfilippo type B
BMN 250 is being developed as enzyme replacement therapy for Sanfilippo type B, a primarily neurological rare disease, in which patients have deficient lysosomal alpha-N-acetylglucosaminidase (NAGLU) enzyme activity. BMN 250 is taken up in target cells by the cation-independent mannose 6-phosphate r...
Na minha lista:
| 發表在: | Drug Deliv Transl Res |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer US
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7066106/ https://ncbi.nlm.nih.gov/pubmed/31942701 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13346-019-00683-6 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|